Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceled

Note that some links may require registration or subscription.

A security guard was killed during a shooting at a New Hampshire psychiatric hospital; no patients were harmed and the suspect has been killed, according to authorities. (CNN, CBS News Boston)

Heavy fighting has erupted around another Gaza hospital. (AP)

Sam Altman, the OpenAI CEO who pushed for the use of ChatGPT in medicine, was fired by the company. (Modern Healthcare)

Former first lady Rosalynn Carter, a humanitarian and mental health advocate, died at age 96. (NBC News)

Medtronic announced FDA approval of its Symplicity Spyral renal denervation system for hypertension.

Salem Hospital in Massachusetts is facing a class action lawsuit after acknowledging hundreds of patients may have been exposed to hepatitis and HIV during routine endoscopies. (CBS News Boston)

President Biden announced his intention to appoint W. Kimryn Rathmell, MD, PhD, of Vanderbilt University Medical Center in Nashville, Tennessee, as the next National Cancer Institute director.

A cancer patient’s dying request — donations to help clear other people’s medical debt — has raised over $450,000, which could wipe out approximately $45 million of debt.

Does Novavax’s COVID vaccine carry fewer side effects? (NBC News)

Only one in four American adults worry they will catch COVID over the holidays, and just about half plan to get the updated vaccine, a KFF COVID-19 Vaccine Monitor survey found.

COVID activity indicators are ticking slightly up, according to the CDC, while the flu is surging in seven U.S. states. (AP)

The American Academy of Pediatrics released guidance on use of fecal microbiota transplantation in children.

Amid the growing neurodiversity movement, a rift has developed over the term “profound autism.” (Washington Post)

Bayer was ordered by a Missouri jury to pay $1.56 billion to plaintiffs who blame Roundup for injuries, including that the weedkiller caused cancer. (Reuters)

Meanwhile, the company said it stopped the phase III OCEANIC-AF trial early due to a lack of efficacy; the study was testing the investigational blood thinner asundexian in atrial fibrillation patients at risk for stroke.

A cholera outbreak in Zimbabwe has been linked with more than 150 deaths and over 8,000 cases. (AP)

The FDA announced a recall of cantaloupes following a Salmonella outbreak associated with 17 hospitalizations across 15 states.

  • author['full_name']

    Shannon Firth has been reporting on health policy as MedPage Today’s Washington correspondent since 2014. She is also a member of the site’s Enterprise & Investigative Reporting team. Follow

Please enable JavaScript to view the

comments powered by Disqus.